Buckley Wealth Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
CS
Buckley Wealth Management's NVAX Position: Q3 2022 in Review
Buckley Wealth Management sold out of Novavax (NVAX) in Q3 2022, closing a stake of 4,000 shares — an estimated $206K sold.
Buckley Wealth Management first reported a position in NVAX in Q3 2021 and held it in 4 quarters. The position peaked at $572K in Q4 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.
- Buckley Wealth Management reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
- Buckley Wealth Management sold 4,000 Novavax shares in Q3 2022, an estimated $206K.
- Buckley Wealth Management first reported a position in Novavax in Q3 2021 and held it in 4 quarters.
- Buckley Wealth Management's Novavax position peaked at $572K in Q4 2021.
- 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.
Based on Buckley Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.